Navigation Links
Hormone Could Improve Diabetes Treatment
Date:6/25/2009

Biomarker might predict how type 2 patients will respond to drugs, study shows

THURSDAY, June 25 (HealthDay News) -- A hormone might be an effective biomarker to help improve treatment of type 2 diabetes, U.S. researchers report.

Adiponectin is a metabolic hormone that regulates a number of processes, including glucose regulation and metabolism of fat for energy production. Previous research has shown an association between adiponectin and insulin sensitivity.

This new study found that levels of the hormone in patients with type 2 diabetes helped predict how patients responded to certain diabetes drugs. The researchers' analysis of data from several clinical trials revealed that levels of adiponectin in the blood are able to predict activation of receptors called PPARs, which assist the genes that help cells respond to insulin.

The results support the possible use of adiponectin as a biomarker to monitor glucose tolerance and to predict patient response to diabetes drugs called thiazolidinediones.

The study appears in the June 24 online edition of Clinical Pharmacology & Therapeutics.

More information

The U.S. National Institute of Diabetes and Digestive Diseases has more about diabetes.



-- Robert Preidt



SOURCE: Clinical Pharmacology & Therapeutics, news release, June 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Appetite-stimulating hormone is first potential medical treatment for frailty in older women
2. MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™
3. Longer Hormone Treatment May Improve Prostate Cancer Outlook
4. Hormone therapy may confer more aggressive properties to prostate tumors
5. Pausing Hormone Therapy Doesnt Cut Mammogram Recalls
6. Fighting "Brain Fog": How the Right Hormones Can Improve Mental Sharpness for Women
7. What You Need to Know in Your 40s to Have a Healthy Menopause -- Without Hormone Replacement Therapy
8. Action of ghrelin hormone increases appetite and favors accumulation of abdominal fat
9. A stronger backbone: DHEA hormone replacement increases bone density in older women
10. Womens International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy
11. Test for hormones in blood not reflective of hormones in breast tissue; breast cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Could Improve Diabetes Treatment 
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: